|
1
|
Chen SL, You J and Wang GJ: Supercritical
fluid extraction of beta-elemene under lower pressure. Se Pu.
19:179–181. 2001.(In Chinese).
|
|
2
|
Zhang X, Zhang Y and Li Y: β-elemene
decreases cell invasion by upregulating E-cadherin expression in
MCF-7 human breast cancer cells. Oncol Rep. 30:745–750. 2013.
|
|
3
|
Bao F, Qiu J and Zhang H: Potential role
of β-elemene on histone H1 in the H22 ascites hepatoma cell line.
Mol Med Rep. 6:185–190. 2012.
|
|
4
|
Wang G, Li X, Huang F, Zhao J, Ding H,
Cunningham C, Coad JE, Flynn DC, Reed E and Li QQ: Antitumor effect
of beta-elemene in non-small-cell lung cancer cells is mediated via
induction of cell cycle arrest and apoptotic cell death. Cell Mol
Life Sci. 62:881–893. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li X, Wang G, Zhao J, Ding H, Cunningham
C, Chen F, Flynn DC, Reed E and Li QQ: Antiproliferative effect of
beta-elemene in chemoresistant ovarian carcinoma cells is mediated
through arrest of the cell cycle at the G2-M phase. Cell Mol Life
Sci. 62:894–904. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhu T, Zhao Y, Zhang J, Li L, Zou L, Yao Y
and Xu Y: β-elemene inhibits proliferation of human glioblastoma
cells and causes cell-cycle G0/G1 arrest via mutually compensatory
activation of MKK3 and MKK6. Int J Oncol. 38:419–426. 2011.
|
|
7
|
Yao YQ, Ding X, Jia YC, Huang CX, Wang YZ
and Xu YH: Anti-tumor effect of beta-elemene in glioblastoma cells
depends on p38 MAPK activation. Cancer Lett. 264:127–134. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhu T, Xu Y, Dong B, Zhang J, Wei Z, Xu Y
and Yao Y: β-elemene inhibits proliferation of human glioblastoma
cells through the activation of gliamaturation factor β and induces
sensitization to cisplatin. Oncol Rep. 26:405–413. 2011.
|
|
9
|
Yao YQ, Xu YH, Lu J, Zhou HY and Wang YZ:
Effect of p38 MAPK on elemene-induced cell cycle arrest in C6
glioblastoma cells. Zhonghua Yi Xue Za Zhi. 88:56–58. 2008.(In
Chinese).
|
|
10
|
Zaheer A, Zaheer S, Sahu SK, Knight S,
Khosravi H, Mathur SN and Lim R: A novel role of glia maturation
factor: induction of granulocyte-macrophage colony-stimulating
factor and pro-inflammatory cytokines. J Neurochem. 101:364–376.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Thangavel R, Kempuraj D, Stolmeier D,
Anantharam P, Khan M and Zaheer A: Glia maturation factor
expression in entorhinal cortex of Alzheimer’s disease brain.
Neurochem Res. 38:1777–1784. 2013.
|
|
12
|
Lim R, Hicklin DJ, Ryken TC, Han XM, Liu
KN, Miller JF and Baggenstoss BA: Suppression of glioma growth in
vitro and in vivo by glia maturation factor. Cancer Res.
46:5241–5247. 1986.PubMed/NCBI
|
|
13
|
Paunovic V and Harnett MM:
Mitogen-activated protein kinases as therapeutic targets for
rheumatoid arthritis. Drugs. 73:101–115. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lo HW: Targeting Ras-RAF-ERK and its
interactive pathways as a novel therapy for malignant gliomas. Curr
Cancer Drug Targets. 10:840–848. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu HZ, Yu C, Yang Z, He JL, Chen WJ, Yin
J, Li WM, Liu HT and Wang YX: Tubeimoside I sensitizes cisplatin in
cisplatin-resistant human ovarian cancer cells (A2780/DDP) through
down-regulation of ERK and up-regulation of p38 signaling pathways.
Mol Med Rep. 4:985–992. 2011.PubMed/NCBI
|
|
16
|
Zhao YS, Zhu TZ, Yao YQ, Liu RY, Wu CM,
Wei ZQ, Wang W and Xu YH: β-elemene inhibits Hsp90/Raf-1 molecular
complex inducing apoptosis of glioblastoma cells. J Neurooncol.
107:307–314. 2012.
|
|
17
|
Zaheer A and Lim R: In vitro inhibition of
MAP kinase (ERK1/ERK2) activity by phosphorylated glia maturation
factor (GMF). Biochemistry. 35:6283–6288. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lim R and Zaheer A: In vitro enhancement
of p38 mitogen-activated protein kinase activity by phosphorylated
glia maturation factor. J Biol Chem. 271:22953–22956. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ali K, Lu Y, Das U, Sharma RK, Wiebe S,
Meguro K, Sadanand V, Fourney DR, Vitali A, Kelly M, et al:
Biomolecular diagnosis of human glioblastoma multiforme using
Synchrotron mid-infrared spectromicroscopy. Int J Mol Med.
26:11–16. 2010.PubMed/NCBI
|
|
20
|
Tao L, Zhou L, Zheng L and Yao M: Elemene
displays anti-cancer ability on laryngeal cancer cells in vitro and
in vivo. Cancer Chemother Pharmacol. 58:24–34. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li QQ, Wang G, Huang F, Banda M and Reed
E: Antineoplastic effect of beta-elemene on prostate cancer cells
and other types of solid tumour cells. J Pharm Pharmacol.
62:1018–1127. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu YH, Dong B, Luo QZ, Zhou HY, Jia YC,
Yang YF and Wang YZ: Influence of elemene on the expression of
Bcl-2 family genes in rat C6 glioma cells. Zhonghua Yi Xue Za Zhi.
85:1700–1703. 2005.(In Chinese).
|
|
23
|
Yao YQ, Xu YH, Zhou HY, Cui CZ and Wang
YZ: Role of ERK in the inhibitory effects of elemene on the
proliferation of rat C6 glioblastoma cells. Tumor. 27:777–779.
2007.
|
|
24
|
Zaheer A, Zaheer S, Thangavel R, Wu Y,
Sahu SK and Yang B: Glia maturation factor modulates
beta-amyloid-induced glial activation, inflammatory
cytokine/chemokine production and neuronal damage. Brain Res.
1208:192–203. 2008. View Article : Google Scholar
|
|
25
|
Zaheer A, Zaheer S, Sahu SK, Yang B and
Lim R: Reduced severity of experimental autoimmune
encephalomyelitis in GMF-deficient mice. Neurochem Res. 32:39–47.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zaheer S, Wu Y, Bassett J, Yang B and
Zaheer A: Glia maturation factor regulation of STAT expression: a
novel mechanism in experimental autoimmune encephalomyelitis.
Neurochem Res. 32:2123–2131. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gandhi M, Smith BA, Bovellan M,
Paavilainen V, Daugherty-Clarke K, Gelles J, Lappalainen P and
Goode BL: GMF is a cofilin homolog that binds Arp2/3 complex to
stimulate filament debranching and inhibit actin nucleation. Curr
Biol. 20:861–867. 2010. View Article : Google Scholar
|
|
28
|
Zaheer A, Knight S, Zaheer A, Ahrens M,
Sahu SK and Yang B: Glia maturation factor overexpression in
neuroblastoma cells activates glycogen synthase kinase-3beta and
caspase-3. Brain Res. 1190:206–214. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zaheer A and Lim R: Protein kinase A
(PKA)- and protein kinase C-phosphorylated glia maturation factor
promotes the catalytic activity of PKA. J Biol Chem. 272:5183–5186.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Reardon DA: Treatment of elderly patients
with glioblastoma. Lancet Oncol. 13:656–657. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sengupta S, Marrinan J, Frishman C and
Sampath P: Impact of temozolomide on immune response during
malignant glioma chemotherapy. Clin Dev Immunol. 2012:8310902012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
El Azreq MA, Naci D and Aoudjit F:
Collagen/β1 integrin signaling up-regulates the ABCC1/MRP-1
transporter in an ERK/MAPK-dependent manner. Mol Biol Cell.
23:3473–3484. 2012.
|
|
33
|
Sato A, Sunayama J, Matsuda K, Seino S,
Suzuki K, Watanabe E, Tachibana K, Tomiyama A, Kayama T and
Kitanaka C: MEK-ERK signaling dictates DNA-repair gene MGMT
expression and temozolomide resistance of stem-like glioblastoma
cells via the MDM2-p53 axis. Stem Cells. 29:1942–1951. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang Y, Qu XJ, Liu YP and Hou KZ: PD98059
enhancing the effects of oxaliplatin on human colorectal cancer RKO
cells mediated by downregulation of GST-π expression. Chin J
Clinicians. 5:6957–6960. 2011.
|
|
35
|
Tomiyasu H, Watanabe M, Goto-Koshino Y,
Fujino Y, Ohno K, Sugano S and Tsujimoto H: Regulation of
expression of ABCB1 and LRP genes by mitogen-activated protein
kinase/extracellular signal-regulated kinase pathway and its role
in generation of side population cells in canine lymphoma cell
lines. Leuk Lymphoma. 54:1309–1315. 2013. View Article : Google Scholar
|
